Outsourcing STREAM
-
Release Your Gene Therapy With Confidence
7/20/2021
You are developing a cell or gene therapy and now you need to deliver it quickly to patients. But first you must make sure it's safe and effective. That's where we come in. Our experts can draw a testing strategy for your specific product, process, and goals.
-
Factors Which Impact mAb Process Scale-Up
9/7/2021
Thinking about your mAb scale-up processes early on can help avoid common pitfalls. Cytiva’s Fast Trak scientists discuss factors that can influence a successful scale-up outcome.
-
Microbiology Testing Systems Maintenance & Repair Services Plans
10/8/2024
Watch to learn about microbiology testing systems maintenance and repair services plans from a company with proven expertise.
-
M Labâ„¢ Collaboration Centers Video
9/1/2022
M Lab™ Collaboration Centers is a network comprised of scientific experts, innovative technologies, and flexible non-GMP facilities where you can troubleshoot your process, identify efficiencies, and adopt innovative techniques.
-
Collaboration & Expertise, The Keys To Efficiency And Scalability Across All Modalities
7/8/2022
View this video and discover our global vaccine capabilities from process development to full-scale GMP-manufacturing and in all modalities.
-
Building LEO Pharma's U.S. Presence with Brian Hilberdink
8/23/2023
In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder. The job's not for the faint of heart, which might be why the Danish company LEO Pharma tapped veteran biopharma leader Brian Hilberdink to lead its U.S. operations.
-
How MilliporeSigma Promotes Quality And Risk Reduction
10/20/2021
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.
-
A Dedicated Team To Safely Store Your Cell And Virus Banks
2/27/2023
The safety of your cell and virus banks must be your top priority. Learn about a team dedicated to the safety of your material along with their related services.
-
MilliporeSigma Large Scale Capabilities Tour
10/20/2021
A detailed look at MilliporeSigma’s new BioReliance® viral vector manufacturing facility and how we have employed the latest innovations and quality systems to deliver best-in-class gene therapy services.
-
Increasing The Reach Of Cell And Gene Therapies
4/29/2021
The cell and gene therapy industry is rapidly evolving from the perspective of “can we commercialize this class of therapeutics?” to “how do we reach patients who need these therapies?”. However, the promise of these biologics can only be realized if the industry approaches manufacturing parity with monoclonal antibodies. A mixture of innovation and brute-force streamlining is needed to create viable cell and gene therapy templates. In this video, we discuss how upstream process optimization is ripe for innovative approaches.